Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on April 3, 2026
Apr. 3, 2026
Crypto News: AlphaPepe Stage 10 Nearly Sold Out Prior Big Price Rise As XRP Eyes $5 Breakout
Indeterminate
GlobeNewswire
Apr. 3, 2026
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Indeterminate
GlobeNewswire
Apr. 3, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Indeterminate
GlobeNewswire
Apr. 3, 2026
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Indeterminate
GlobeNewswire
Apr. 3, 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
Apr. 3, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
ClimateTech Connect Announces Global Pitch Competition Finalists Ahead of Next Week's Conference
Indeterminate
GlobeNewswire
Apr. 3, 2026
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
GAMIVO Unveils Analysis on 2026's Most Popular Video Game Genres
Indeterminate
GlobeNewswire
Apr. 3, 2026
Rhythm Pharmaceuticals Announces Changes to Board of Directors
Indeterminate
GlobeNewswire